Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity M Tardelli, K Zeyda, V Moreno-Viedma, B Wanko, NG Grün, G Staffler, ... Molecular metabolism 5 (11), 1131-1137, 2016 | 77 | 2016 |
Serum myostatin is upregulated in obesity and correlates with insulin resistance in humans M Amor, BK Itariu, V Moreno-Viedma, M Keindl, A Jürets, G Prager, ... Experimental and Clinical Endocrinology & Diabetes 127 (08), 550-556, 2019 | 74 | 2019 |
EPHA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer G Martini, C Cardone, PP Vitiello, V Belli, S Napolitano, T Troiani, ... Molecular Cancer Therapeutics 18 (4), 845-855, 2019 | 71 | 2019 |
Common dysregulated pathways in obese adipose tissue and atherosclerosis V Moreno-Viedma, M Amor, A Sarabi, M Bilban, G Staffler, M Zeyda, ... Cardiovascular diabetology 15, 1-12, 2016 | 50 | 2016 |
Osteopontin affects macrophage polarization promoting endocytic but not inflammatory properties K Schuch, B Wanko, K Ambroz, A Castelo‐Rosa, V Moreno‐Viedma, ... Obesity 24 (7), 1489-1498, 2016 | 40 | 2016 |
Vitamin A deficiency increases protein catabolism and induces urea cycle enzymes in rats G Esteban-Pretel, MP Marín, F Cabezuelo, V Moreno, J Renau-Piqueras, ... The Journal of nutrition 140 (4), 792-798, 2010 | 38 | 2010 |
Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state M Tardelli, V Moreno‐Viedma, M Zeyda, BK Itariu, FB Langer, G Prager, ... Journal of gastroenterology and hepatology 32 (1), 253-260, 2017 | 35 | 2017 |
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer C Cardone, B Blauensteiner, V Moreno-Viedma, G Martini, V Simeon, ... European Journal of Cancer 138, 1-10, 2020 | 30 | 2020 |
Differential sensitivity to adrenergic stimulation underlies the sexual dimorphism in the development of diabetes caused by Irs-2 deficiency MJ Garcia-Barrado, MC Iglesias-Osma, V Moreno-Viedma, MFP Mansilla, ... Biochemical pharmacology 81 (2), 279-288, 2011 | 25 | 2011 |
AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M M Tardelli, FV Bruschi, T Claudel, V Moreno-Viedma, E Halilbasic, ... Scientific Reports 7 (1), 14661, 2017 | 21 | 2017 |
Adiponectin regulates AQP3 via PPARα in human hepatic stellate cells M Tardelli, T Claudel, FV Bruschi, V Moreno-Viedma, M Trauner Biochemical and Biophysical Research Communications 490 (1), 51-54, 2017 | 21 | 2017 |
Identification of matrix metalloproteinase-12 as a candidate molecule for prevention and treatment of cardiometabolic disease M Amor, V Moreno-Viedma, A Sarabi, NG Grün, B Itariu, L Leitner, ... Molecular Medicine 22, 487-496, 2016 | 15 | 2016 |
AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M. Sci Rep 2017; 7: 14661 M Tardelli, FV Bruschi, T Claudel, V Moreno-Viedma, E Halilbasic, ... | 5 | |
AXL has a prognostic role in metastatic colorectal cancer (mCRC) and is a predictive biomarker of lack of efficacy of chemotherapy (CT)+ cetuximab in RAS wild type (WT … C Cardone, B Blauensteiner, V Moreno-Viedma, MC Paul, G Martini, ... Annals of Oncology 29, viii30, 2018 | 3 | 2018 |
A humanized osteopontin mouse model and its application in immunometabolic obesity studies NG Grün, K Zeyda, V Moreno-Viedma, K Strohmeier, G Staffler, M Zeyda, ... Translational Research 178, 63-73. e2, 2016 | 3 | 2016 |
Eph A2 expression is a predictive biomarker of poorer activity and efficacy of FOLFIRI+ cetuximab in RAS WT metastatic colorectal cancer (mCRC) patients (pts) in the CAPRI GOIM … C Cardone, MC Paul, V Moreno-Viedma, G Martini, PP Vitiello, ... Annals of Oncology 28, v576, 2017 | 2 | 2017 |
Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice NG Grün, K Strohmeier, V Moreno-Viedma, M Le Bras, C Landlinger, ... Immunology letters 179, 85-94, 2016 | 2 | 2016 |
Inducible overexpression of a FAM3C/ILEI transgene has pleiotropic effects with shortened life span, liver fibrosis and anemia in mice U Schmidt, B Uluca, I Vokic, B Malik, T Kolbe, C Lassnig, M Holcmann, ... PloS one 18 (9), e0286256, 2023 | 1 | 2023 |
AXL expression predicts poor prognosis and lack of efficacy of anti-angiogenic and anti-epidermal growth factor receptor (EGFR) agents in patients (pts) with RAS wild type (WT … C Cardone, B Blauensteiner, V Moreno-Viedma, PP Vitiello, G Martini, ... Annals of Oncology 30, v37-v38, 2019 | 1 | 2019 |
Abstract A013: Role of EGFR in KRAS-mediated resistances in colorectal cancer. E Adachi-Fernandez, V Moreno-Viedma, D Krauss, A Kirchmair, ... Molecular Cancer Research 21 (5_Supplement), A013-A013, 2023 | | 2023 |